May 4, 2023
DUPIXENT® (dupilumab injection) is now Approved in Canada for the Treatment of Adult and Adolescent Patients (12+) With Eosinophilic Esophagitis
May 1, 2023
Libtayo® (cemiplimab) in Combination with Chemotherapy now approved in Canada for the First-line Treatment of Advanced Non-small Cell Lung Cancer
April 24, 2023
Health Canada Approves BEYFORTUS™ (nirsevimab) for the Prevention of RSV Disease in Infants
No current content.